Table 3.
Distribution of absolute and relative frequency of research units based on the symptoms, treatment phases and groups14 days after the intervention
| Before treatment | 14 days after treatment | |||||
|---|---|---|---|---|---|---|
| Case | Control | p-value | Case | Control | p-value | |
| Itching | 30(85.7) | 32(91.4) | 0.71 | 1(2-9) | 9(25.7) | 0.02 |
| Irritation | 27(77.1) | 24(68.6) | 0.59 | 1(2.9) | 8(22.9) | 0.04 |
| Dysuria | 18(51.8) | 20(57.6) | 0.81 | 0(0) | 3(8.6) | 0.35 |
| Dyspareunia | 25(71.4) | 22(62.9) | 0.61 | 4(11.4) | 8(22.9) | 0.59 |
| Discharge | 26(74.3) | 29(82.9) | 0.56 | 1(2.9) | 8(22.9) | 0.04 |